Impact Investing in Cardiovascular Disease

Broadview’s mission is to accelerate the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.

Getting Treatments to Patients

Broadview’s mission is to accelerate the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.

Diversified Portfolio Across Technologies

Broadview’s mission is to accelerate the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.

OUR PORTFOLIO

View All

PRESS

Jan 12, 2026
Abbott and AtaCor Medical Collaborate on Advanced Extravascular ICD Technology
Read More
Jan 8, 2026
FineHeart secures €83 million to support its growth and establish itself as a future European leader in Active Implantable Medical Devices (AIMDs)
Read More
Jan 8, 2026
Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
Read More
Jan 6, 2026
Acesion Pharma starts Phase 2 trial of AP31969 in patients with atrial fibrillation
Read More
View All